Last Updated : February 16, 2018
Details
Project Line:
New at CADTH
Final Biosimilar Summary Dossier Issued:
Drug Reimbursement Recommendations
CADTH Common Drug Review
- Migalastat (Galafold): Fabry Disease
- Cysteamine bitartrate (Procysbi): Nephropathic cystinosis
- Glecaprevir pibrentasvir (Maviret): Chronic Hepatitis C
- Apomorphine hydrochloride (Movapo): Parkinson's disease
- Sofosbuvir velpatasvir voxilaprevir (Vosevi): Chronic Hepatitis C
CADTH pan-Canadian Oncology Drug Review (pCODR)
- Pembrolizumab (Keytruda): classical Hodgkin Lymphoma (cHL)
- Irinotecan Liposome (Onivyde): Metastatic Pancreatic Cancer
Cancer Drug Pipeline Information
The Cancer Drug Pipeline Information for Patient Groups is updated each month.
Health Technology Management Products
Rapid Response
Reports completed in January.
Recent Summaries of Evidence With Critical Appraisals Include:
- Per Oral Endoscopic Myotomy for Esophageal Motility Disorders: A Review of Clinical, Cost-Effectiveness, and Guidelines
- Early Mobilization for Patients with Venous Thromboembolism: A Review of Clinical Effectiveness and Guidelines
- Human Growth Hormone Treatment for Children with Prader-Willi Syndrome: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines
- Intravenous Lidocaine for Chronic Pain: A Review of the Clinical Effectiveness and Guidelines
Horizon Scanning
Issues in Emerging Health Technologies
Issue 165 — Alternating Electric Fields ("Tumour- Treating Fields") for the Treatment of Glioblastoma
CADTH Resources
Read the latest “Evidence Matters” column in Hospital News: “An innovation in cancer treatment: Do we need proton beam therapy here?”
Evidence Bundles
Our evidence bundles are a collection of the best CADTH evidence on a variety of topics for decision-makers:
Resources to Address the Opioid Crisis
See our evidence bundles on www.cadth.ca/opioids and www.cadth.ca/pain for our latest work in these areas. Below is a snapshot of several reports that are currently in progress:
- Concomitant use of opioids and central nervous system depressants (like benzodiazepines)
- Alpha2-adrenergic agonists for the reduction or discontinuation of opioids or opioid substitution therapy
- Emerging non-opioid drugs for the treatment of pain
News and Events
2018 is going to be a big year for health technology assessment in Canada! We hope you can join us in Halifax and Vancouver.
2018 CADTH Symposium
Registration is now open for our 2018 Symposium, which will be held in Halifax from April 15 to 17, 2018.
Our Call for Late-Breaking Abstracts is open until Friday, February 16. Read more about the criteria.
Our preliminary program is now available. Check out the list of workshops, presenters, and plenary speakers.
We regularly update information and make announcements about special dates on our website. Be the first to know what’s new by subscribing to our Symposium newsletter.
HTAi 2018 Vancouver
We are pleased to be co-hosting the HTAi 2018 Annual Meeting in Vancouver from June 1 to 5, 2018.
CADTH Lecture Series
Register now! On Tuesday, February 27, 2018, Dr. Matthew Seftel will present his CADTH Lecture, Gene Therapy: A Scientific Renaissance? Dr. Seftel is Head of the Department of Medical Oncology and Hematology at CancerCare Manitoba and Associate Professor of the section of Hematology/Oncology, Department of Internal Medicine, at the University of Manitoba.
On February 22, Dr. Brian O’Rourke, President and Chief Executive Officer, CADTH, will be a keynote presenter at the forum Doing the Right Thing... Right: Evidence Informing Clinical Decision-Making, along with Dr. Sean Tunis, President, Health Technology Assessment International. The event is jointly hosted by the Institute Health Economics (IHE), Alberta Health, and CADTH, in Edmonton.
Evidence-to-Action Event Live from Symposium: Canadian Medical Imaging Inventory
We invite you to attend the launch event of the 2017 Canadian Medical Imaging Inventory (CMII), which provides the latest facts about the location, prevalence, and use of specialist medical imaging equipment across Canada. The launch will be held during the 2018 CADTH Symposium in Halifax on April 16, 2018, from 3:15 p.m. to 4:30 p.m. EST, and will also be broadcast via live stream across the country, free for anyone to attend, but you must register. To attend the event in person you must be a CADTH Symposium Delegate or an invited guest.
Beyond CADTH
ECRI Institute Sheds Unbiased Light on New Healthcare Innovations for 2018: Annual Top 10 list gives evidence-based insight into apps for opioid addiction, genetic testing, acuity-adaptable rooms, and virtual reality for pediatrics. (Registration is required to view report.)
Tell Us What You Think
We love hearing how our products and services are influencing health care policies, clinical practices, and patient outcomes. If you have a success story to share, please get in touch with your CADTH Liaison Officer.
CADTH E-Alerts: Subscribe to receive the latest CADTH news, reports, feedback opportunities, and events.
Last Updated : February 16, 2018